Skip to main content

Table 1 Characteristics of 17 patients with hepatocellular carcinoma undergoing liver transplantation

From: Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

Pt No. Pt Group Sex Age Viral
Hepatitis
Liver cirrhosis
Child-Pugh
Pre-OLT
BCLC
Histology AFP
(ng/mL)
Pre-OLT
Treatment
Donor Type Relapse
Location
Post Relapse
Treatment
Sorafenib
Dose (mg)
Current
Status
1 Adjuvant M 50 HBV A B N/A N/A TACE CD Liver TACE, R/T 400 PD
2 Adjuvant M 50 HBV A A Mod. Diff. 3.29 OP, RFA CD Nil Nil 600 CR
3 Adjuvant M 55 HBV A B N/A 3115 Nil CD Nil Nil 400 CR
4 Adjuvant M 61 HCV A B Mod. Diff. 153 TACE, RFA CD Nil Nil 400 CR
5 Adjuvant M 51 HBV B B P. Diff. 25.4 TACE CD Nil Nil 400 CR
6 Palliative M 56 HBV C D N/A 12.31 TACE CD Potal vein Nil 400 PD
7 Palliative M 48 HBV A C N/A 5567 TACE, RFA CD Liver TACE, R/T 800 Dead
8 Palliative M 51 HBV B C P. Diff. 22.12 TACE LD Lung C/T 400 CR
9 Palliative M 48 HBV A B P. Diff. 5.07 Nil CD Liver R/T, RFA 800 Dead
10 Palliative F 61 HCV B D N/A 7745 TACE, RFA CD Lung Nil 200 Dead
11 Palliative M 55 HBV C D N/A N/A Nil CD Portal vein R/T 400 Dead
12 Control F 78 HCV A B N/A N/A TACE CD Lung Nil Nil Dead
13 Control M 39 HBV A C P. Diff. 24.21 TACE CD Liver TACE, OP, C/T Nil Dead
14 Control M 57 HBV B C P. Diff. 6.38 TACE CD Liver OP Nil Dead
15 Control F 62 HCV A C N/A 9058 OP, RFA CD Liver TACE Nil Dead
16 Control M 62 HCV A C Mod. Diff. 13.74 TACE CD Nil Nil Nil Dead
17 Control F 62 HCV C C P. Diff. 98589 Nil LD Lung Nil Nil Dead
  1. Pt: patient, M: male, F: female, HBV: hepatitis B virus, HCV: hepatitis C virus, OLT: orthopedic liver transplant, BCLC: Barcelona Clinic Liver Cancer, N/A: not available, Mod. Diff.: moderately differentiated, P. Diff.: poorly differentiated, AFP: alpha-fetoprotein, N/A: not available, TACE: transarterial chemoembolisation, OP: operation, RFA: radiofrequency ablation, CD: cadaveric donor, RFA: radiofrequency ablation, CD: cadaveric donor, LD: living donor, R/T: radiotherapy, C/T: chemotherapy, PD: progressive disease, CR: complete remission, RFA: radiofrequency ablation, CD: cadaveric donor, LD: living donor, R/T: radiotherapy, C/T: chemotherapy, PD: progressive disease, CR: complete remission